- Zepbound (tirzepatide) is a prescription-only, once-weekly injection — the strength you use, when you move up, and when you hold or step back are decisions your prescriber makes for you, not a schedule to copy from an article.
- It comes in six FDA-approved strengths (2.5, 5, 7.5, 10, 12.5, and 15 mg); the 2.5 mg starter dose is not an approved maintenance dose — its only job is to let your body adjust.
- The FDA label uses gradual dose escalation starting low, with at least four weeks between planned increases, but your clinician tailors the actual timing to how you tolerate it.
- Never increase, "catch up," split, share, or restart Zepbound on your own, and do not use unregulated compounded or counterfeit tirzepatide — the FDA has warned about both, and mass compounding ended after the 2025 shortage resolution.
- Zepbound is FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity, always alongside diet and activity.
- For a suspected overdose or a serious reaction, call Poison Control at 1-800-222-1222 or 911.
- The Six FDA-Approved Zepbound Strengths
- Why Doses Start Low and Step Up Gradually
- Why the Starter Dose Is Not a Weight-Loss Dose
- How Much Weight Loss the Studies Showed
- Increasing, Holding, and Stepping Back — a Prescriber’s Call
- Missed or Delayed Doses
- Avoid Compounded and Counterfeit Tirzepatide
- Maintenance and Stopping
- Beyond Weight: the Sleep Apnea Indication
- Frequently Asked Questions
- Can I move through Zepbound doses faster to lose weight sooner?
- How long do people stay on the 2.5 mg starter dose?
- Is 15 mg Zepbound the same as 15 mg Mounjaro?
- What should I do if I miss my weekly injection?
- Do all Zepbound strengths cost the same?
- The Bottom Line on Zepbound Dosing
- Related guides
Zepbound (tirzepatide) is prescribed in six different strengths, and people searching for Zepbound doses usually want to know how the numbers fit together. Here is the most important thing to understand first: Zepbound is a prescription-only medicine that must be titrated under a prescriber’s supervision. The strength you use, when you move up, and when you hold or step back down are individualized clinical decisions your prescriber makes for you — not a calendar to copy from an article. This guide explains the approved strengths, why the dose starts low and increases gradually, and why the schedule belongs to your clinician.
The Six FDA-Approved Zepbound Strengths
Zepbound is a once-weekly subcutaneous injection supplied in prefilled single-dose pens (and a KwikPen). According to the FDA prescribing information, the available strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Each pen delivers a single fixed dose — there is no mixing, drawing up, or adjusting the amount yourself.
The lowest strength, 2.5 mg, is a starter dose only. Eli Lilly states plainly that 2.5 mg is the starting dose and is not an approved maintenance dose. Its job is to let your gastrointestinal system adjust to GLP-1 and GIP receptor activation before any therapeutic dose is reached. The maintenance doses studied for weight management sit higher, and which one is right for you is something your prescriber decides based on your response and tolerance.
Why Doses Start Low and Step Up Gradually
The FDA label uses gradual dose escalation, starting low. The reason is tolerability: tirzepatide slows stomach emptying and changes appetite signaling, and raising the dose too quickly sharply increases the risk of nausea, vomiting, and dehydration. Starting at 2.5 mg and increasing in steps gives the gut time to adapt so that most people can eventually reach an effective dose with far fewer side effects.
The label describes waiting at least four weeks before a planned increase, but that is a framework, not a self-serve schedule. Your prescriber sets the actual timing, may keep you at a dose longer, and may hold or step you back down if side effects are significant. Treat the label figures as what the label describes, set by your prescriber — not as a plan to follow on your own.
Why the Starter Dose Is Not a Weight-Loss Dose
A common frustration in the first month is that the scale barely moves. That is expected. The 2.5 mg dose is sub-therapeutic on purpose. If it were strong enough to cause significant appetite suppression from day one, the side effects would be intolerable for most new users. Think of the first weeks as a priming phase rather than a treatment phase.
Nausea, constipation, and burping are most common early on as the gut adapts, and they usually ease over the first few weeks. If symptoms are still rough when your prescriber planned to increase, they may keep you at the current strength longer or add supportive measures. That is a clinical judgment call, and it is exactly the kind of decision that should come from your prescriber rather than a fixed timetable.
How Much Weight Loss the Studies Showed
Most people do not need to climb to the highest strength. In the SURMOUNT-1 trial published in the New England Journal of Medicine, participants were randomized to 5, 10, or 15 mg, and all three doses produced clinically meaningful weight loss. If you are losing weight steadily and tolerating a lower dose well, many obesity-medicine clinicians will keep you there rather than push higher. The “right” maintenance dose is the lowest one that gives you a good result with acceptable side effects — a target your prescriber defines with you.
Increasing, Holding, and Stepping Back — a Prescriber’s Call
Real-world dosing is flexible, but that flexibility belongs to your clinician, not to you. Prescribers routinely hold patients at a dose when side effects linger, or step back down a level after severe nausea or vomiting, then re-attempt the increase later. These adjustments are normal and are not a failure — they are how the medicine is managed safely.
Do not escalate on your own to “speed things up,” and never split a pen, share pens, or use someone else’s prescription. Jumping ahead is associated with much higher rates of severe nausea, vomiting, and gallbladder problems, without producing faster results. If you feel your dose should change, contact the person who prescribed it. For cost context across strengths, see our Zepbound price breakdown.
Missed or Delayed Doses
Zepbound is injected once weekly. The FDA label addresses missed doses, but the safe move is to follow the exact instructions your prescriber and pharmacy gave you rather than a general rule from an article — and to call your pharmacist if you are unsure. Do not “double up” to make up for a missed week; stacking doses amplifies side effects without improving results.
If you have been off Zepbound for a couple of weeks or longer — because of a supply gap, insurance lapse, or illness — do not assume you can simply restart at your previous strength. Tolerance to these effects fades quickly, and your prescriber may want to restart at a lower dose. Always check before resuming after a gap.
Avoid Compounded and Counterfeit Tirzepatide
During the 2022–2024 shortage, compounded “tirzepatide” was widely sold online. With the shortage resolved, the FDA has moved to end large-scale compounding of tirzepatide (verify the current status), and the agency has repeatedly warned about counterfeit and unregulated products that may contain the wrong ingredient, the wrong amount, or no active drug at all. Dosing figures on those products cannot be trusted, and there is no quality guarantee. Use only FDA-approved Zepbound obtained through a licensed pharmacy with a valid prescription.
Maintenance and Stopping
There is no universal “stop dose” for Zepbound. Obesity is treated as a chronic condition, and the Obesity Medicine Association notes that most patients who stop GLP-1/GIP therapy regain a significant portion of lost weight. Maintenance generally means staying on the lowest dose that keeps your weight stable, which differs from person to person. Whether to taper off, and how, is an individualized decision to make with your prescriber alongside sustained lifestyle changes — not something to attempt on your own. Related reading: our tirzepatide side effects guide and the medical conditions pillar.
Beyond Weight: the Sleep Apnea Indication
Zepbound is FDA-approved not only for chronic weight management in adults with obesity (or overweight with a weight-related condition) but also for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, used together with a reduced-calorie diet and increased activity. If you are treated for OSA, your prescriber still sets and adjusts the dose the same careful way. Keep any devices or therapies your sleep clinician has prescribed unless told otherwise.
When to seek emergency care: Call 911 or go to the ER for severe or persistent abdominal pain (which can signal pancreatitis or a gallbladder problem), signs of a serious allergic reaction (swelling of the face, lips, or throat, or trouble breathing), or severe vomiting with signs of dehydration. For a suspected overdose or medication error, call Poison Control at 1-800-222-1222 (free, 24/7).
Frequently Asked Questions
Can I move through Zepbound doses faster to lose weight sooner?
No. The gradual step-up exists to limit nausea, vomiting, and gallbladder complications, and skipping ahead does not produce faster weight loss — it just raises the risk of side effects. Only your prescriber should change your dose or its timing.
How long do people stay on the 2.5 mg starter dose?
The 2.5 mg strength is a starter dose, not an approved maintenance dose, so it is not meant to be used long-term on its own. How long you stay there before your prescriber increases it depends on how you are tolerating it. Talk to your clinician rather than adjusting the timing yourself.
Is 15 mg Zepbound the same as 15 mg Mounjaro?
The active ingredient is the same — tirzepatide — at the same strength. The difference is the FDA-labeled indication: Zepbound is for chronic weight management and obstructive sleep apnea, Mounjaro for type 2 diabetes. They are not interchangeable at will, and you should not switch products without your prescriber. See our Mounjaro savings card guide for cost differences.
What should I do if I miss my weekly injection?
Follow the specific instructions from your prescriber and pharmacy, and call your pharmacist if you are unsure. Do not double up to make up a missed dose, and check before restarting if you have been off for two weeks or more.
Do all Zepbound strengths cost the same?
List and self-pay pricing can vary over time and by pharmacy, and Lilly has offered lower-cost self-pay options (including the KwikPen at the same self-pay prices as vials) — verify current pricing before you fill. Insurance coverage and savings programs also change what you actually pay. Our Zepbound price guide and healthcare costs guide cover current savings strategies.
The Bottom Line on Zepbound Dosing
Zepbound’s dosing is not arbitrary: doses start low and step up gradually so your body can build tolerance to a medicine that changes how your gut, brain, and pancreas signal about food. But the schedule is a clinical tool, not a checklist for readers — the strength, the timing of any increase, and every hold or step-down are decisions for the prescriber who is monitoring you. Take Zepbound exactly as prescribed, use only FDA-approved product from a licensed pharmacy, and bring any questions about your dose to your clinician rather than adjusting it yourself.
Medical disclaimer: This article is for general education only and is not medical advice. It intentionally does not provide a self-follow dosing or titration schedule. Zepbound (tirzepatide) is a prescription-only medication that must be prescribed, dosed, adjusted, and monitored by a licensed clinician. Do not start, increase, split, share, or restart it on your own, and do not use compounded or counterfeit tirzepatide. Follow your prescriber’s instructions and your pharmacy label. For a suspected overdose or medication error, call Poison Control at 1-800-222-1222 or 911.
